iStent inject® W
iStent inject® W is indicated for use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild to moderate primary open-angle glaucoma. iStent inject® W is the gold standard in micro-invasive glaucoma surgery (MIGS), continuing the legacy of excellence set throughout 20 years of iStent® devices. It’s backed by the most robust, diverse, and longest-term body of clinical evidence for any MIGS procedure available today, driven through clinical rigor and integrity.
Key Advantages
Optimized Outflow
Two multi-directional stents designed to restore natural outflow
Clinically Proven
Significant IOP reduction across a wide range of clinical studies 1 2
Procedural Elegance
Predictability and precision meet the needs of your practice
Proven Safety
Safety profile similar to cataract surgery alone1
Mechanism of Action: Restoring the Natural Outflow Pathway
iStent inject® W creates two patent bypass pathways through the trabecular meshwork—the main source of resistance for aqueous outflow—resulting in multi-directional flow through Schlemm’s canal. And it is one of the smallest medical devices known to be implanted in the human body. Together, these unique advantages are designed to provide exceptional results in a truly micro-invasive approach.
Optimize Outflow with the iStent inject® W
Glaukos trabecular micro-bypass stents are placed two to three clock hours apart. The stents are multi-directional and together, they are designed to deliver access to multiple collector channels and arcs of flow that can span five to six clock hours. The stents may also re-establish flow in previously dormant outflow channels.3
Prioritizing Safety and Outcomes
Putting the primary emphasis on maximizing benefits and minimizing long-term complications, iStent inject® W is designed to support optimal outcomes after cataract surgery and much more:
- Micro-invasive and astigmatically-neutral
- Utilizes the conventional outflow pathway
- Leaves natural anatomy intact, preserving the potential for future treatment options, including drug delivery devices
- Minimally traumatic to delicate eye tissue and spares conjunctival tissue
- Reduces risk of hypotony by utilizing the natural episcleral venous pressure
- Offers postoperative care profile similar to cataract surgery
Exceptional Elegance. Advanced Innovatio
The iStent inject® W System is engineered to provide an enhanced surgical experience and ensure confident delivery, for every procedure. With a streamlined injector system and next-generation stent design, featuring a wide flange at its base, iStent inject® W is designed to optimize stent visualization and placement, enhance procedural predictability, and increase peace of mind.
Our Gallery
